Rachel M. Presti, MD, PhD

Rachel M. Presti, MD, PhD

Professor, Infectious Diseases | Medical Director of the Infectious Disease Clinical Research Unit (IDCRU)

Rachel Presti, MD, PhD, is the Medical Director of the Infectious Disease Clinical Research Unit (IDCRU), which conducts clinical and translational research trials in HIV, PrEP, hepatitis, COVID-19, influenza, STIs, fungal infections, vaccines, microbiome and other infectious disease.  IDCRU has been an AIDS Clinical Trials Site since 1987.  She also co-directs the Center for Vaccine Research.

Dr. Presti specializes in clinical and translational research in infectious disease, with a special focus on HIV, SARS-CoV-2 and other viral infections.  She has a background in immunology and also has an interest in facilitating translational research in vaccine development as well as viral pathogenesis.  She attends on the general ID consult services teaching fellows, residents, and students. She also sees patients in the virology clinic.

She is currently mentoring fellows and junior faculty in HIV and clinical trials.